Presented by Beth Rutkowski, MPH
Friday, December 8th, 2023
9:00AM - 10:00AM HST
Location: Zoom
Hawaiʻi SUPD trainings are held in conjunction with the Thompson School of Social Work & Public Health Continuing Education and Professional Development (CEPD) Program. If you are no longer able to attend the training, please withdraw your registration via the link in your registration confirmation email.
This program is approved for up to 5.0 continuing education contact hour(s) by the Alcohol and Drug Abuse Division (#ADAD-24-813) and by the National Association of Social Workers – Hawaiʻi Chapter (NASWHI-CEP-005) for up to 5.0 Social Work continuing education contact hour(s).
This training is co-sponsored by:
At the end of this webinar, participants will be able to:
1. Name three (3) health effects of xylazine in humans.
2. Distinguish two (2) major types of harm caused by xylazine use, in both short- and long-term contexts.
3. Explain three (3) overdose prevention tools or strategies.
Beth Rutkowski, MPH, has been associated with UCLA Integrated Substance Abuse Programs (ISAP) since December 2000, and currently serves as the Director of Training and Co-Director of the SAMHSA-funded Pacific Southwest Addiction Technology Transfer Center. The majority of Ms. Rutkowski’s time is focused on the development of synchronous and asynchronous training and intensive technical assistance activities and products and based on evidence-based substance use disorder research and targeted to the community at large. In addition, she organizes and conducts conferences and trainings throughout the Pacific Southwest region (HHS Region 9, covering AZ, CA, HI, NV, and the six U.S. Affiliated Pacific Jurisdictions) on scientifically validated interventions and topics. Ms. Rutkowski has co-authored and edited several peer reviewed research articles, book chapters, special issues, and technical reports on a variety of topics related to the treatment of substance use disorders.
